NDC11 70436001506
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70436-0015-06 | 70436-0015 |
| 70436-0015-6 | 70436-0015 |
| 70436-015-06 | 70436-015 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE | Slate Run Pharmaceuticals, LLC | a469adff-25a6-4983-b471-60924d920a86 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 70436-015-06 70436-015 70436001506 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.